Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,157 public trials 553 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

NCT03500315

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
View all 29 locations
View Trial Details
Completed

An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

NCT03740230

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • SoonChunHyang University CheonAn Hospital /ID# 209996 Cheonan-si, Chungcheongnam-do, South Korea
  • Hallym University Sacred Heart Hospital /ID# 210809 Anyang, Gyeonggido, South Korea
  • The Catholic University of Korea, Bucheon St.Mary's Hospital /ID# 216869 Bucheon-si, Gyeonggido, South Korea
  • Dongguk University Ilsan Hospital /ID# 210609 Goyang, Gyeonggido, South Korea
View all 61 locations
View Trial Details
Completed

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

NCT02741128

Conditions
Acquired Immunodeficiency Syndrome, Arbovirus Infections, Blood-Borne Infections, +24 more
Locations
  • Investigational Site Number :0760002 Nova Iguaçu, Rio de Janeiro, Brazil
  • Investigational Site Number :0760004 Natal, Rio Grande do Norte, Brazil
  • Investigational Site Number :0760001 São Paulo, Brazil
  • Investigational Site Number :0760003 São Paulo, Brazil
View Trial Details
Completed

A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells

NCT03856996

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States
View Trial Details
Completed

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

NCT03980223

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Behavior, +21 more
Locations
  • San Francisco City Clinic / San Francisco Department of Public Health San Francisco, California, United States
  • University of California, San Francisco / Zuckerberg San Francisco General Hospital/UCSF San Francisco, California, United States
  • University of Washington Seattle, Washington, United States
View Trial Details

Related conditions